Gilead Sciences, Inc. (NASDAQ: GILD) reported Q4 EPS of $0.97, $0.08 worse than the analyst estimate of $1.05. Revenue for the quarter came in at $2.2 billion versus the consensus estimate of $2.18 billion.

For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.

Earnings